Anacetrapib Reduces the Risk of Major Coronary Events in Patients With Atherosclerotic Vascular Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Effects of Anacetrapib in Patients With Atherosclerotic Vascular Disease
N. Engl. J. Med 2017 Aug 28;[EPub Ahead of Print], The HPS3/TIMI55-REVEAL Collaborative GroupFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.